151 related articles for article (PubMed ID: 31217732)
21. Knockdown of HMGN5 suppresses the viability and invasion of human urothelial bladder cancer 5637 cells in vitro and in vivo.
Gan Y; Tan J; Yang J; Zhou Y; Dai Y; He L; Yao K; Tang Y
Med Oncol; 2015 Apr; 32(4):136. PubMed ID: 25796505
[TBL] [Abstract][Full Text] [Related]
22. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
23. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
[TBL] [Abstract][Full Text] [Related]
24. B7‑H3 promotes malignant progression of muscle‑invasive bladder cancer.
Xu ZL; Zhang Y; Wang L; Li F; Man HW; Li PF; Shan BE
Oncol Rep; 2018 Nov; 40(5):2722-2733. PubMed ID: 30132557
[TBL] [Abstract][Full Text] [Related]
25. Structural maintenance of chromosomes 2 is identified as an oncogene in bladder cancer in vitro and in vivo.
Han YH; Wan Y; Xiong H; Sun GL
Neoplasma; 2020 Mar; 67(2):364-370. PubMed ID: 31986889
[TBL] [Abstract][Full Text] [Related]
26. Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth.
Zhang H; Jiang H; Wang W; Gong J; Zhang L; Chen Z; Ding Q
Urol Oncol; 2012; 30(6):920-7. PubMed ID: 21478038
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.
Hsieh HY; Jou YC; Tung CL; Tsai YS; Wang YH; Chi CL; Lin RI; Hung SK; Chuang YM; Wu SF; Li C; Shen CH; Chan MWY; Hsu CD
Oncogene; 2018 Feb; 37(5):673-686. PubMed ID: 29035390
[TBL] [Abstract][Full Text] [Related]
28. Inducing cell growth arrest and apoptosis by silencing long non-coding RNA PCAT-1 in human bladder cancer.
Liu L; Liu Y; Zhuang C; Xu W; Fu X; Lv Z; Wu H; Mou L; Zhao G; Cai Z; Huang W
Tumour Biol; 2015 Sep; 36(10):7685-9. PubMed ID: 25934337
[TBL] [Abstract][Full Text] [Related]
29. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
Han Y; Liu Y; Nie L; Gui Y; Cai Z
Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
[TBL] [Abstract][Full Text] [Related]
30. IL‑23 concentration‑dependently regulates T24 cell proliferation, migration and invasion and is associated with prognosis in patients with bladder cancer.
Wang P; Zhang Y; Zhang J; Jiang J; Jin F; Sun Z
Oncol Rep; 2018 Dec; 40(6):3685-3693. PubMed ID: 30542702
[TBL] [Abstract][Full Text] [Related]
31. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
[TBL] [Abstract][Full Text] [Related]
32. Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder.
Miyake M; Hori S; Morizawa Y; Tatsumi Y; Toritsuka M; Ohnishi S; Shimada K; Furuya H; Khadka VS; Deng Y; Ohnishi K; Iida K; Gotoh D; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Tanaka N; Konishi N; Fujimoto K
Oncotarget; 2017 May; 8(22):36099-36114. PubMed ID: 28415608
[TBL] [Abstract][Full Text] [Related]
33. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
[TBL] [Abstract][Full Text] [Related]
34. AID modulates carcinogenesis network via DNA demethylation in bladder urothelial cell carcinoma.
Li H; Li Q; Ma Z; Zhou Z; Fan J; Jin Y; Wu Y; Cheng F; Liang P
Cell Death Dis; 2019 Mar; 10(4):251. PubMed ID: 30874539
[TBL] [Abstract][Full Text] [Related]
35. Metallothionein 3 Is a Hypoxia-Upregulated Oncogene Enhancing Cell Invasion and Tumorigenesis in Human Bladder Carcinoma Cells.
Tsui KH; Hou CP; Chang KS; Lin YH; Feng TH; Chen CC; Shin YS; Juang HH
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813460
[TBL] [Abstract][Full Text] [Related]
36. In vitro modulation of implantation and intraepithelial expansion of bladder tumor cells by epidermal growth factor.
Bindels EM; Vermey M; Rebel JM; Zwarthoff EC; Van Der Kwast TH
Exp Cell Res; 1997 Sep; 235(2):395-402. PubMed ID: 9299164
[TBL] [Abstract][Full Text] [Related]
37. PLCε promotes urinary bladder cancer cells proliferation through STAT3/LDHA pathway‑mediated glycolysis.
Cheng H; Hao Y; Gao Y; He Y; Luo C; Sun W; Yuan M; Wu X
Oncol Rep; 2019 May; 41(5):2844-2854. PubMed ID: 30864733
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-325 Is a Potential Biomarker and Tumor Regulator in Human Bladder Cancer.
Lin T; Zhou S; Gao H; Li Y; Sun L
Technol Cancer Res Treat; 2018 Jan; 17():1533033818790536. PubMed ID: 30176759
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer.
Zhang Z; Zhang G; Gao Z; Li S; Li Z; Bi J; Liu X; Li Z; Kong C
BMC Cancer; 2017 Dec; 17(1):861. PubMed ID: 29246203
[TBL] [Abstract][Full Text] [Related]
40. Expression of bone morphogenetic protein-10 (BMP10) in human urothelial cancer of the bladder and its effects on the aggressiveness of bladder cancer cells in vitro.
Zhang N; Ye L; Wu L; Deng X; Yang Y; Jiang WG
Anticancer Res; 2013 May; 33(5):1917-25. PubMed ID: 23645739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
